These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 12881707

  • 21. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
    Singal R, van Wert J, Bashambu M.
    Cancer Res; 2001 Jun 15; 61(12):4820-6. PubMed ID: 11406558
    [Abstract] [Full Text] [Related]

  • 22. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
    Takada H, Wakabayashi N, Dohi O, Yasui K, Sakakura C, Mitsufuji S, Taniwaki M, Yoshikawa T.
    Cancer Genet Cytogenet; 2010 Feb 15; 197(1):16-24. PubMed ID: 20113832
    [Abstract] [Full Text] [Related]

  • 23. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.
    El-Osta A, Kantharidis P, Zalcberg JR, Wolffe AP.
    Mol Cell Biol; 2002 Mar 15; 22(6):1844-57. PubMed ID: 11865062
    [Abstract] [Full Text] [Related]

  • 24. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 25. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells.
    Kim B, Rincón Castro LM, Jawed S, Niles LP.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):45-8. PubMed ID: 18550052
    [Abstract] [Full Text] [Related]

  • 26. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
    Wong CM, Ng YL, Lee JM, Wong CC, Cheung OF, Chan CY, Tung EK, Ching YP, Ng IO.
    Hepatology; 2007 May 28; 45(5):1129-38. PubMed ID: 17464989
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T.
    Oncogene; 2004 Jul 08; 23(31):5340-9. PubMed ID: 15107822
    [Abstract] [Full Text] [Related]

  • 39. Histone deacetylation directs DNA methylation in survivin gene silencing.
    Ma AN, Lu J, Zhou XJ, Wang YX.
    Biochem Biophys Res Commun; 2011 Jan 07; 404(1):268-72. PubMed ID: 21130077
    [Abstract] [Full Text] [Related]

  • 40. Analysis of chromatin-immunopurified MeCP2-associated fragments.
    El-Osta A, Wolffe AP.
    Biochem Biophys Res Commun; 2001 Dec 07; 289(3):733-7. PubMed ID: 11726209
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.